Autoimmune drug pipelines

Celgene

Ozanimod

Multiple sclerosis (relapsing)

Phase III


Biogen

BIIB061

Multiple sclerosis

Phase I


Biogen

Opicinumab

Multiple sclerosis

anti-LINGO

Phase II


Biogen

Ocrelizumab

Multiple sclerosis (primary progressive & relapsing)

monoclonal antibody targeting CD20-positive B cells

Phase III


Biogen

Natalizumab

Secondary progressive multiple sclerosis

Phase III